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The alginate lyase-encoding gene (algL) of Azotobacter chroococcum was localized to a 3.1-kb EcoRI DNA
fragment that revealed an open reading frame of 1,116 bp. This open reading frame encodes a protein of 42.98
kDa, in agreement with the value previously reported by us for this protein. The deduced protein has a
potential N-terminal signal peptide that is consistent with its proposed periplasmic location. The analysis of
the deduced amino acid sequence indicated that the gene sequence has a high homology (90% identity) to the
Azotobacter vinelandii gene sequence, which has very recently been deposited in the GenBank database, and that
it has 64% identity to the Pseudomonas aeruginosa gene sequence but that it has rather low homology (15 to 22%
identity) to the gene sequences encoding alginate lyase in other bacteria. The A. chroococcum AlgL protein was
overproduced in Escherichia coli and purified to electrophoretic homogeneity in a two-step chromatography
procedure on hydroxyapatite and phenyl-Sepharose. The kinetic and molecular parameters of the recombinant
alginate lyase are similar to those found for the native enzyme.
Alginates are linear polysaccharides composed of (1,4)-
linked b-D-mannuronic acid and its C-5 epimer, a-L-guluronic
acid. These uronic acids are arranged in block structures which
may be homopolymeric (polymannuronic acid or polyguluronic
acid) or heteropolymeric random sequence (15). The propor-
tion and arrangement of the block structures vary greatly in
alginates from different sources and determine the physical
properties of the polymer, particularly the ability to form gels
in the presence of divalent cations (21). Alginates are synthe-
sized as cell wall components by brown seaweeds and as exo-
polysaccharides by two families of heterotrophic bacteria,
Pseudomonadaceae and Azotobacteriaceae. Marine alga algi-
nate is used widely in the food, pharmaceutical, textile, and oil
industries. Bacterial alginate is an acetylated polymer of D-
mannuronic and L-guluronic acids, and evidence has been pre-
sented for the location of O-acetyl groups at the 2 and/or 3
position of D-mannuronosyl residues (41). In their pioneering
work, Lawson and Stacey (26) described the existence of two
capsular polysaccharides in Azotobacter chroococcum, and,
more recently, one of these exocellular polysaccharides was
identified as an alginate (9). In cystic fibrosis patients, Pseudo-
monas aeruginosa produces alginate, which facilitates the at-
tachment of the bacterium to tracheal mucins. The exopolysac-
charide protects the microorganism from phagocytes and
prevents antibiotic uptake. Consequently, it is a major patho-
genic factor in these patients (3).
Alginates are degraded by a group of enzymes that catalyze
the b-elimination of the 4-O-linked glycosidic bond, with for-
mation of unsaturated uronic acid-containing oligosaccharides
(6). Several of the bacteria that synthesize alginate-like poly-
saccharides also produce alginate lyases, but they cannot use
the polymers as the sole carbon and energy source. Typically,
alginate lyases have an absolute specificity for either D-man-
nuronic or L-guluronic acid at the nonreducing side of the bond
to be cleaved but no limitation on the uronic acids at the
reducing side (5). Although alginate lyase may prove useful in
the elucidation of alginate molecular structure, its degrading
action on alginate represents a drawback in the bioproduction
of the polymer by fermentation. In studies of P. aeruginosa, it
is necessary to look for inhibitors of alginate synthesis with
potential use as therapeutic agents in cystic fibrosis patients.
Therefore, research on this enzyme is important from different
points of view.
In this paper, we describe the cloning of the algL gene
encoding the alginate lyase from A. chroococcum and the pu-
rification and characterization of its product. We also report
the conditions under which the enzyme can be overproduced in
Escherichia coli and easily purified to electrophoretic homoge-
neity.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. A. chroococcum ATCC
4412 was grown at 30°C on nitrogen-free Burk’s medium supplemented with
0.5% (wt/vol) sucrose as the sole energy and carbon source.
E. coli DH5a (Bethesda Research Laboratories) was used for all plasmid
constructions, E. coli MC1061 (30) was used for gene library construction, and E.
coli BL-21 (DE3) (40) was used as the host for pAPET-2 to produce alginate
lyase. These strains were grown on Luria-Bertani (LB) and M9 minimal media
containing ampicillin (100 mg/ml) as described by Sambrook et al. (37).
P. aeruginosa 8830, a gift from A. M. Chakrabarty (University of Illinois,
Chicago), was grown as described by May and Chakrabarty (29) to isolate alginic
acid, which was used as substrate for A. chroococcum alginate lyase.
Plasmid pRL500 (12) was used to construct the partial A. chroococcum gene
library, and pBluescript II SK(1) (Stratagene) was used as cloning vector. Plas-
mid pET-3a, used for the expression of recombinant proteins, was from Nova-
gen. pCL8, containing alginate lyase gene (algL) from P. aeruginosa (4), was a gift
from A. M. Chakrabarty. Plasmids pAPL4.7 and pAPET-2, containing the algL
gene from A. chroococcum, were constructed for this work.
DNA manipulation and Southern blot hybridization. Total DNA from A.
chroococcum was isolated as described by Ausubel et al. (1). All DNA manipu-
lations and E. coli transformations were performed by standard procedures (37).
DNA fragments were purified from agarose gels by using the GeneClean kit (Bio
101, Inc.). For Southern hybridization, DNA was digested and fragments were
electrophoresed on 0.7% agarose gels with the Tris-borate-EDTA buffer system
(37). DNA was transferred to Z-probe membranes (Bio-Rad) under vacuum,
and Southern blot hybridizations were performed as described by Ausubel et al.
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(1). DNA probes were 32P labelled with a DNA-labelling kit (-dCTP) (Pharma-
cia) and [a-32P]dCTP (Amersham).
Cloning of the algL gene. Genomic DNA from A. chroococuum was completely
digested with EcoRI and fractionated on a 0.7% agarose gel. DNA fragments of
approximately 2.0 to 4.0 kb were purified and ligated into the EcoRI site of
pRL500. E. coli MC1061 was transformed with the ligation mixture, and trans-
formants were grown on LB agar plates containing ampicillin. Transformants
were screened for the presence of the algL gene by colony hybridization blotting
with a 1.8-kb XbaI-EcoRI fragment from plasmid pCL8 as a probe.
DNA sequencing and nucleotide sequence analysis. DNA fragments contain-
ing the algL gene were subcloned into pBluescript II SK(1) and sequenced by
the dideoxy chain termination method (38) with M13 universal and reverse
oligonucleotides or synthetic oligonucleotides as primers. Sequencing reactions
were carried out with Sequenase version 2.0 (US Biochemical Corp.). Nested
unidirectional deletions were generated with the double-stranded nested-dele-
tion kit (Pharmacia LKB). Both strands of DNA were sequenced.
Computer sequence analysis was carried out with the Genetics Computer
Group software package (10). Amino acid sequences were compared with the
FASTA program, and alignments were produced with the PileUp program and
default parameters (33).
Expression of AlgL and purification of alginate lyase. To express AlgL pro-
tein, a PCR with plasmid template pAPL4.7 and primers designed to introduce
the NdeI (59-TATTCATATGAAGACCAGACTTGCCC-39) and BamHI (59-C
TTCGGGATCCCTGCGGAATACCAG-39) restriction sites encompassing algL
was performed by using a final volume of 50 ml that contained 1.5 ng of DNA
from plasmid pAPL4.7, 0.2 mM each deoxynucleoside triphosphate, 50 pmol of
each oligonucleotide, and 2.5 U of Taq polymerase and 13 buffer (Boehringer).
An expected PCR product of 0.2 kb containing BamHI and NdeI sites was
amplified. It was digested with NdeI and BamHI, ethanol precipitated, and
ligated into a similarly digested and phosphatase-treated pET-3a expression
plasmid. Possible constructs were confirmed by restriction digestion and se-
quencing.
To create pAPET-2, a 1.8-kb BstXI-EcoRV fragment from pAPL4.7 (contain-
ing the algL gene) was isolated and cloned in pET-3a (containing the PCR
product) previously digested with BamHI, refilled by a Klenow reaction, and
finally digested with BstXI. This plasmid contained the whole A. chroococcum
algL gene under the control of the T7/lac promoter; in consequence, its expres-
sion was inducible by isopropyl-b-D-thiogalactopyranoside (IPTG).
E. coli BL-21 (DE3) cells were transformed with plasmid pAPET-2. Transfor-
mation mixtures were used to directly inoculate 2 liters of M9 minimal medium
containing 100 mg of ampicillin per ml. The culture was incubated at 30°C to an
absorbance at 550 nm (A550) of 0.5; at this time, T7 polymerase was induced by
adding IPTG at a final concentration of 1 mM, and cells were incubated for
another 3 h at 30°C. Then cells were collected by centrifugation (8,000 3 g for 5
min), and the periplasmic fraction was prepared as described by Efterkhar and
Schiller (11). The periplasmic proteins were loaded onto a hydroxyapatite col-
umn (1.8 by 14 cm) equilibrated with 20 mM potassium phosphate buffer (pH
7.5). The adsorbed alginate lyase activity was eluted with a linear gradient of 0.1
to 1.0 M potassium phosphate buffer (pH 7.5). Most active fractions were pooled
and loaded onto a phenyl-Sepharose column (1 by 8 cm) equilibrated with 25
mM Tris-HCl buffer (pH 8.2) containing 1 M NaCl. The alginate lyase activity
was eluted within the void volume of this column. Most active fractions were
combined and used as the purified AlgL enzyme.
Alginate lyase assay. As the substrate for the enzyme assay, alginic acid from
either Macrocystis pyrifera (60% mannuronate; Sigma), A. chroococcum, or P.
aeruginosa was used. Alginic acid from A. chroococcum was prepared as de-
scribed by Jarman et al. (22), and that from P. aeruginosa was prepared as
described by May and Chakrabarty (29). When needed, the substrate from P.
aeruginosa was deacetylated before being used as substrate (16). Alginate lyase
activity was quantitatively measured by the thiobarbituric acid method (42).
Enzyme preparations (5 to 15 mg of total protein) in 50 mM Tris-HCl buffer (pH
7.5)–0.2 M MgCl2 containing substrate (0.1 mg) were incubated at 30°C for 15
min. One unit of enzyme activity is defined as the amount of enzyme required to
generate 1 mmol of b-formylpyruvate per min. The protein concentration was
measured by the method of Bradford (8) with bovine serum albumin (Sigma) as
the standard.
Alginate lyase plate assay. Alginate lyase-producing E. coli strains were iden-
tified by being grown at 37°C on LB plates containing 1% agarose, alginate from
the seaweed M. pyrifera (2 mg/ml), and 100 mg of ampicillin per ml. The plates
were stained by flooding with 10% (wt/vol) cetylpyridinium chloride, and clear
zones of depolymerization on a white background were observed, indicating lyase
activity (17).
SDS-PAGE. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) analysis was done by the method of Laemmli (24). Enzymatic activity
after SDS-PAGE and subsequent renaturation were visualized exactly as de-
scribed previously (34). All PAGE runs were performed at room temperature
with a Bio-Rad mini Protean slab gel apparatus.
Nucleotide sequence accession number. The nucleotide sequence of the A.
chroococcum algL gene (see Fig. 3) has been deposited in the DDBJ, EMBL, and
GenBank DNA databases under accession no. AJ223605.
RESULTS AND DISCUSSION
Cloning of the A. chroococcum algL gene. To clone algL, total
genomic DNA from A. chroococcum was digested and sub-
jected to Southern blotting with, as the probe, a 1.8-kb XbaI-
EcoRI fragment from plasmid pCL8, containing the algL gene
from P. aeruginosa (4). A 3.2-kb EcoRI fragment hybridized
with this probe (data not shown). Total A. chroococcum DNA
was then digested with EcoRI, and fragments of approximately
2.0 to 4.0 kb were purified and ligated to pRL500 to construct
a partial A. chroococcum gene library. Transformants in E. coli
MC1061 were screened for the presence of the algL gene by
using the same probe (see Materials and Methods). A positive
clone was analyzed. This clone contained a 3.1-kb EcoRI in-
sert, which was cloned into pBluescript to generate plasmid
pAPL4.7 for further analysis (Fig. 1).
To determine whether this DNA fragment encoded the al-
ginate lyase enzyme, E. coli DH5a cells were transformed with
pAPL4.7 and tested for alginate lyase activity on LB plates
containing alginate. A clear zone of depolymerization was ob-
served around cells containing pAPL4.7. Untransformed E.
coli DH5a did not synthesize an endogenous activity that was
able to degrade alginate, and DH5a cells containing the pBlue-
script vector showed no clear zones (Fig. 2). Therefore, the
3.1-kb EcoRI fragment harbors the alginate lyase enzyme from
A. chroococcum.
Nucleotide sequence of the algL gene. To determine if the
3.1-kb fragment contains the bonafide algL gene from A.
chroococcum, nested deletions were generated from pAPL4.7
with exonuclease III and a number of the resulting clones were
checked for alginate lyase activity to locate the algL gene in the
FIG. 1. Restriction map of pAPL4.7 and pAPET-2 containing the A. chroo-
coccum algL gene. Thin lines and open bars correspond to vector plasmid DNA
and cloned DNA fragments, respectively. The coding region is represented by
solid bars. A broken arrow indicates the direction of the transcription of algL. E,
EcoRI; A, ApaI; B, BstXI, S, SacI; N, NdeI; EV, EcoRV. Potential algX and algI
genes upstream and downstream of algL gene are indicated by solid arrow
underlines.
FIG. 2. Plate assay for alginate lyase activity. Cells were restreaked on LB
plates containing alginate and assayed for alginate lyase activity (see Materials
and Methods). 1, untransformed E. coli DH5a cells; 2, E. coli DH5a cells
containing pAPL4.7 plasmid; 3, E. coli cells containing pBluescript SK(1) plas-
mid.
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pAPL4.7 plasmid and were used for sequencing. The complete
nucleotide sequence of algL gene and its translation of the
open reading frame into a 372-residue amino acid sequence
are shown in Fig. 3. The coding region ends with a TAG stop
codon and it encodes a polypeptide with a calculated molecu-
lar mass of 42.98 kDa. As reported previously, the molecular
mass of the alginate lyase from A. chroococcum, determined by
activity staining after SDS-PAGE and subsequent renatur-
ation, is 43 kDa (34) and the molecular mass estimated by gel
filtration is about 46 kDa (35). A potential Shine-Dalgarno
(GAGG) sequence lies just 7 nucleotides upstream from the
start site. In the region of DNA upstream of the ATG codon,
sequences related to the 235 and 210 consensus promoter
regions were not identified. The G1C content of the nucleo-
tide sequence is 67.2%, in good agreement with the value
found for the Azotobacter genes, which is within 65 to 68% (2).
When sequences contained in plasmid pAPL4.7 flanking the
algL open reading frame were sequenced and compared with
other nucleotide sequences deposited in the data banks, it was
observed that these sequences showed homologies to those of
P. aeruginosa algX and algI genes, which are constituents of the
alginate biosynthesis operon (14, 31). These data suggest that
FIG. 3. Nucleotide sequence of A. chroococcum algL and deduced amino acid sequence of its product. The deduced amino acid sequence of AlgL is shown in
single-letter code below the nucleotide sequence of algL. The possible Shine-Dalgarno sequence is indicated by a dotted underline. The initial methionine is indicated
by an asterisk, and the possible signal peptide is indicated by a solid underline.
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the A. chroococcum algL gene is probably located in an operon
and has, as flanking genes, the algX gene at its 59 end and the
algI gene at its 39 end. The existence of an alginate biosynthesis
operon has also been described for A. vinelandii (13). The
sequence of the algXLIVFA operon from A. vinelandii (as ap-
peared in the GenBank database) indicates that the alginate
biosynthesis operon in this organism has the same structure as
the one described in the present report for A. chroococcum.
The flanking sequences of the A. chroococcum algL gene show
a high homology to the recently reported sequence of the
algXLIVFA operon from A. vinelandii.
Deduced amino acid sequence of AlgL. The deduced protein
sequence of AlgL was compared with entries in the GenBank
and SWISS-PROT databases. Multiple alignment of several
alginate lyase sequences indicates that A. chroococcum AlgL is
more similar to P. aeruginosa AlgL (63.6% identity) than to K.
pneumoniae AlgL (16.3% identity), P. alginovora DlgL (16.3%
identity), or Photobacterium DlgL (18.8%). As mentioned
above, the A. vinelandii AlgL deduced amino acid sequence
(GenBank) is very similar (90% identity) to that from A. chroo-
coccum.
The presence at the N-terminal region of a signal peptide of
20 to 30 amino acids, rich in hydrophobic residues, had been
described for several alginate lyases (4, 27, 28, 39). This signal
peptide has not been experimentally investigated in A. chroo-
coccum, but the hydrophobicity profile deduced from the algL
gene shows a highly hydrophobic region of 25 amino acids at
the amino-terminal end. A potential cleavage site appears be-
tween amino acid residues Ala22 and Ala23. This zone has high
homology to the amino acid sequence of the signal peptide
described for P. aeruginosa. These data suggest the existence of
a signal peptide in A. chroococcum alginate lyase and the
maturing of this protein. The mature protein would then begin
at Ala23. Processing and export through the inner membrane
are consistent with the periplasmic location of AlgL in A.
chroococcum (35) and its purification from the periplasmic
fraction from E. coli.
Purification and characterization of recombinant alginate
lyase. The algL gene was expressed from the bacteriophage T7
polymerase promoter of pET-3a expression vector. The final
construct, called pAPET-2, was transformed in E. coli BL21
(DE3), and the AlgL enzyme was produced following induc-
tion of T7 polymerase. The best conditions for the overexpres-
sion of the enzyme were direct culture inoculation from the
transformation mixture, 30°C, initiation of induction by adding
1 mM IPTG at an A550 of 0.5, and an induction time of 3 h.
These conditions prevented the overexpressed protein from
aggregation into inclusion bodies.
The gene product of algL was purified 10.4-fold from the
periplasm fraction of E. coli BL21 (DE3)(pAPET-2), with a
recovery of 6% by hydroxyapatite chromatography and phenyl-
Sepharose column chromatography (Table 1). The final prep-
aration gave a single band on SDS-PAGE with a molecular
mass of approximately 43 kDa (Fig. 4). This value is in good
agreement with the value estimated from the deduced amino
acid sequence of AlgL and with the value determined by ac-
tivity staining in SDS-PAGE for the native AlgL from A. chroo-
coccum (34).
In agreement with other reports, which have described the
partial purification of AlgL from both A. chroococcum and A.
vinelandii (23), attempts to purify the native protein to homo-
geneity were unsuccessful even though a variety of purification
steps were used. In this case, the recovery of partially purified
enzyme (0.06 mg/liter of culture) was also lower than the ob-
tained with the overexpressed alginate lyase (0.36 mg/liter).
To characterize the purified enzyme, it was found that the
optimum temperature for the recombinant enzyme assay is
30°C at pH 7.5 and that alginate lyase was inactive when ana-
lyzed at 70°C (Fig. 5). These values are rather similar to those
for the native enzyme (data not shown).
The enzyme activity was measured in the presence of cations
at 100 mM. Like the native protein (35), the activity of recom-
binant AlgL increased in the presence of Na1 and K1; the
combined action of these cations and Mg21 increased the
activity 100-fold with respect to the control without added
cations (Table 2). When these monovalent and divalent cations
were used at concentrations in the range from 1 to 50 mM, the
FIG. 4. SDS-PAGE analysis of the recombinant A. chroococcum AlgL pro-
tein. (A) Gel stained with Coomassie brilliant blue R-250; (B) alginate lyase
activity detected on a gel containing 1% alginic acid. Lanes: M, molecular mass
markers; 1, periplasmic fraction (10 mg); 2, hydroxyapatite column AlgL fraction
(10 mg); 3, phenyl-Sepharose AlgL fraction (10 mg).
















Periplasmic fraction 69.35 641.7 9.25 100 1
Hydroxyapatite 5.6 331.8 59.25 51.7 6.4
Phenyl-Sepharose 0.36 33.8 93.88 5.26 10.14
a The enzyme was purified from 5 g (fresh mass) of E. coli BL-21 (DE3)
containing plasmid pAPET-2.
FIG. 5. Optimum temperature for the recombinant alginate lyase assay. Ali-
quots (25 ml) of an enzyme preparation (1.5 mU/ml) were analyzed for activity at
the indicated temperatures, and the values found after a 30-min assay were
spectrographically recorded at 548 nm by the thiobarbituric acid method.
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increase in alginate lyase activity was not significant. Other
cations, like Ca21, Co21, Mn21, and Zn21 or the presence of
EDTA does not affect the enzymatic activity. This enhancing
effect of Mg21 on alginate lyase activity has been reported for
the enzyme from Klebsiella aerogenes (25), P. alginovora (7),
and a marine bacterium that has not been identified (36). In all
these cases, the presence of Mg21 is stimulative but is not
essential for the activity. There are other situations, however,
where the cations are strictly required. Thus, Bacillus circulans
JBH2 alginate lyase requires Mg21 (18), and a Pseudomonas
sp., P. aeruginosa, and Littorina sp. alginate lyase depends on
Ca21 (16). The enzyme from A. chroococcum 4A1M is acti-
vated by Ca21 and inhibited strongly by Hg21 (19). It should be
mentioned that the enzyme from A. chroococcum 4A1M has a
molecular mass of 23 kDa by SDS-PAGE and 24 kDa by gel
filtration. Therefore, its molecular mass is roughly half that of
the enzyme found in, and isolated by us from, A. chroococcum
ATCC 4412. Furthermore, the enzyme from strain 4A1M
showed maximum activity at 60°C whereas the one used in the
present work has maximum activity at 30°C.
The Km value for the recombinant A. chroococcum alginate
lyase was found to be 0.08 mM for uronic acids, which is in the
range from 0.1 to 0.5 mM reported for other alginate lyases
(16). From a Lineweaver-Burk double-reciprocal plot, a Vmax
value of 0.183 mM min21 was calculated for the enzyme.
To study the substrate specificity, the recombinant alginate
lyase was used to degrade a series of alginates and the activity
was assayed. AlgL was 17-fold more active against alginate
from the seaweed M. pyriferia than against that from P. aerugi-
nosa. The enzymatic activity against the A. chroococcum algi-
nate was lower than with both above-mentioned substrates.
Alginate from P. aeruginosa was 37% acetylated, but that from
M. pyriferia was completely deacetylated. Therefore, it is likely
that the acetylation of the bacterial alginate confers some pro-
tection against depolymerization by alginase. In favor of this
conclusion is the fact that after chemical deacetylation of the
Pseudomonas alginate, A. chroococcum AlgL increased its ac-
tivity around 10-fold.
Finally, the possible roles of alginate lyases in some envi-
ronments and several potential applications for both the oli-
gosaccharides derived from the action of alginase and the
enzyme itself have recently been discussed (41). Along these
lines, Murata et al. (32) reported that they obtained an alginate
lyase in large quantity and suggested its possible value as a
therapeutic agent for the treatment of cystic fibrosis patients
infected with mucoid P. aeruginosa. In fact, the use of alginate
lyases to degrade the alginate in the lungs of cystic fibrosis
patients, allowing a major diffusion of antibiotic, has been
recently reported (20). The alginate lyase from A. chroococcum
could be used as therapeutic agent because, as mentioned
above, it is able to degrade the alginate produced by P. aerugi-
nosa.
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H. Stolp, H. G. Trüper, A. Balows, H. G. Schlegel (ed.), The prokaryotes.
Springer-Verlag KG, Berlin, Germany.
3. Boyd, A., and A. M. Chakrabarty. 1994. Role of alginate lyase in cell de-
tachment of Pseudomonas aeruginosa. Appl. Environ. Microbiol. 60:2355–
2359.
4. Boyd, A., M. Ghosh, T. B. May, D. Shinaberger, R. Koegh, and A. M.
Chakrabarty. 1993. Sequence of the algL gene of Pseudomonas aeruginosa
and purification of its alginate lyase product. Gene 131:1–8.
5. Boyd, J., and J. R. Turvey. 1977. Isolation of a poly-a-L-guluronate lyase
from Klebsiella aerogenes. Carbohydr. Res. 57:163–171.
6. Boyd, J., and J. R. Turvey. 1978. Structural studies of alginic acid using a
bacterial poly-a-L-guluronate lyase. Carbohydr. Res. 66:187–194.
7. Boyen, C., Y. Bertheau, T. Barbeyront, and G. B. Kloare. 1990. Preparation
of guluronate lyase from Pseudomonas alginovora for protoplast isolation in
Laminaria. Enzyme Microb. Technol. 12:885–890.
8. Bradford, M. 1976. A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye bind-
ing. Anal. Biochem. 72:248–254.
9. Cote, G. L., and L. H. Krull. 1988. Characterization of the exocellular
polysaccharides from Azotobacter chroococcum. Carbohydr. Res. 181:143–
152.
10. Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of
sequence analysis programs for the VAX. Nucleic Acids Res. 12:387–395.
11. Efterkhar, F., and N. L. Schiller. 1994. Partial purification and character-
ization of a manuronan-specific alginate lyase from Pseudomonas aeruginosa.
Curr. Microbiol. 29:37–42.
12. Elhai, J., and C. Wolk. 1988. A versatile class of positive-selection vectors
based on the nonviability of palindrome containing plasmid that allows
cloning into long polylinker. Gene 68:119–138.
13. Fialho, A. M., N. A. Zielinski, W. F. Fett, A. M. Chakrabarty, and A. Berry.
1990. Distribution of alginate gene sequences in the Pseudomonas rRNA
homology group I-Azomonas-Azotobacter lineage of superfamily B pro-
caryotes. Appl. Environ. Microbiol. 56:436–443.
14. Franklin, M. J., and D. E., Ohman. 1996. Identification of algI and algJ in the
Pseudomonas aeruginosa alginate biosynthetic gene cluster which are re-
quired for alginate O acetylation. J. Bacteriol. 178:2186–2195.
15. Gacesa, P. 1988. Alginates. Carbohydr. Polym. 8:161–182.
16. Gacesa, P. 1992. Enzymic degration of alginates. Int. J. Biochem. 24:545–
552.
17. Gacesa, P., and F. S. Wusteman. 1990. Plate assay for simultaneous detec-
tion of alginate lyase and determination of substrate specificity. Appl. Envi-
ron. Microbiol. 56:2265–2267.
18. Hansen, J. B., R. S. Doubet, and J. Ram. 1984. Alginase enzyme production
by Bacillus circulans. Appl. Environ. Microbiol. 47:704–709.
19. Haraguchi, K., and Kodama, T. 1996. Purification and properties of poly(b-
D-mannuronate) lyase from Azotobacter chroococcum. Appl. Microbiol. Bio-
technol. 44:576–581.
20. Hatch, R. A., and Schiller, N. L. 1998. Alginate lyase promotes diffusion of
aminoglycosides through the extracellular polysaccharide of mucoid Pseudo-
monas aeruginosa. Antimicrob. Agents Chemother. 42:974–977.
21. Haug, A., B. Larsen, and E. Baardseth. 1969. Comparison of the constitution
of alginates from differents sources. Proc. Int. Seaweed Symp. 6:443–451.
22. Jarman, T. R., L. Deavin, S. Scolombe, and R. C. Righelato. 1978. Investi-
gation of the effect of environmental conditions on the rate of exopolysac-
charide synthesis in Azotobacter vinelandii. J. Gen. Microbiol. 107:59–64.
23. Kennedy, L., K. McDowell, and I. W. Sutherland. 1992. Alginases from
Azotobacter species. J. Gen. Microbiol. 138:2465–2471.
24. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of
the head of bacteriophage T4. Nature 227:680–685.
25. Lange, B., J. Wingender, and U. K. Winkler. 1989. Isolation and character-
ization of an alginate lyase from Klebsiella aerogenes. Arch. Microbiol. 152:
302–308.
TABLE 2. Effect of different monovalent and divalent cations on
alginate lyase activity assaya





K1 plus Mg21........................................................................ 0.927
Mg21 plus Na1...................................................................... 0.018
K1 plus Mg21 plus Na1 ...................................................... 1.059
a Aliquots of a purified A. chroococcum alginate lyase preparation (30 mU)
were assayed for enzyme activity in the presence of the indicated cations at 100
mM (final concentration) each. Other experimental conditions were as in the
thiobarbituric acid assay, except that 10 mM Tris-HCl buffer (pH 7.5) was used.
VOL. 181, 1999 A. CHROOCOCCUM ALGINATE LYASE 1413































26. Lawson, G. L., and M. Stacey. 1954. Immunopolysaccharides. I. Preliminary
studies of a polysaccharide from Azotobacter chroococcum containing an
uronic acid. J. Chem. Soc. 1954:1925–1931.
27. Maki, H., A. Mori, K. Fujiyama, S. Kinoshita, and T. Yoshida. 1993. Clon-
ing, sequence analysis and expression in Escherichia coli of a gene encoding
an alginate lyase form Pseudomonas sp. OS-ALG-9. J. Gen. Microbiol.
139:987–993.
28. Malissard, M., C. Duez, M. Guinand, M.-J. Vacheron, G. Michel, N. Marty,
B. Joris, T. Thamm, and J.-M. Ghuysen. 1993. Sequence of a gene encoding
a (polyManA) alginate lyase active on Pseudomonas aeruginosa alginate.
FEMS Microbiol. Lett. 110:101–106.
29. May T. B., and A. M. Chakrabarty. 1994. Isolation and assay of Pseudomonas
aeruginosa alginate. Methods Enzymol. 235:295–304.
30. Meissner, P. S., W. P. Sisk, and M. L. Berman. 1987. Bacteriophage 1
cloning system for the construction of directional cDNA libraries. Proc. Natl.
Acad. Sci. USA 84:4171–4175.
31. Monday, S. R., and N. L. Schiller. 1996. Alginate synthesis in Pseudomonas
aeruginosa: the role of AlgL (alginate lyase) and AlgX. J. Bacteriol. 178:625–
632.
32. Murata, K., T. Inose, T. Hisano, S. Abe, Y. Yonemoto, T. Yamashita, M.
Takagi, K. Sakaguchi, A. Kimura, and T. Imanaka. 1993. Bacterial alginate
lyase: enzymology, genetics and application. J. Ferment. Bioeng. 76:427–437.
33. Pearson, W., and D. Lipman. 1988. Improved tools for biological sequence
comparison. Proc. Natl. Acad. Sci. USA 85:2444–2448.
34. Peciña, A., and A. Paneque. 1994. Detection of alginate lyase by activity
staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
subsequent renaturation. Anal. Biochem. 217:124–127.
35. Peciña, A. 1997. Ph.D. thesis. University of Seville, Seville, Spain.
36. Romeo, A., and J. F. Preston. 1986. Purification and structural properties of
an extracellular (134)-b-D-mannuronan specific alginate lyase from a ma-
rine bacterium. Biochemistry 25:8385–8391.
37. Sambrook, J., E. Fritsch, and T. Maniatis. 1989. Molecular cloning: a lab-
oratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, N.Y.
38. Sanger, F., S. Nicklen, and A. Coulson. 1977. DNA sequencing with chain-
terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463–5467.
39. Schiller, N. L., S. R. Monday, C. M. Boyd, N. T. Keen, and D. E. Ohman.
1993. Characterization of the Pseudomonas aeruginosa alginate lyase gene
(algL): cloning, sequencing, and expression in Escherichia coli. J. Bacteriol.
175:4780–4789.
40. Studier, F. W., and B. A. Moffatt. 1986. Use of bacteriophage T7 RNA
polymerase to direct selective high-level expression of clones genes. J. Mol.
Biol. 189:113–130.
41. Sutherland, I. W. 1995. Polysaccharide lyases. FEMS Microbiol. Lett. 16:
323–347.
42. Weissbach, A., and J. Hurwitz. 1958. The formation of 2-keto-3-deoxy hep-
tonic acid in extracts of Escherichia coli B. I and II. J. Biol. Chem. 234:705–
712.
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